AMED RSI Chart
Last 7 days
-1.1%
Last 30 days
-1.3%
Last 90 days
-3.5%
Trailing 12 Months
12.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 2.2B | 2.2B | 2.2B | 2.2B |
2022 | 2.2B | 2.2B | 2.2B | 2.2B |
2021 | 2.1B | 2.2B | 2.2B | 2.2B |
2020 | 2.0B | 2.0B | 2.0B | 2.1B |
2019 | 1.7B | 1.8B | 1.9B | 2.0B |
2018 | 1.5B | 1.6B | 1.6B | 1.7B |
2017 | 1.5B | 1.5B | 1.5B | 1.5B |
2016 | 1.3B | 1.4B | 1.4B | 1.4B |
2015 | 1.2B | 1.2B | 1.2B | 1.3B |
2014 | 1.2B | 1.2B | 1.2B | 1.2B |
2013 | 1.4B | 1.4B | 1.3B | 1.2B |
2012 | 1.5B | 1.5B | 1.5B | 1.4B |
2011 | 1.6B | 1.5B | 1.5B | 1.5B |
2010 | 1.5B | 1.6B | 1.6B | 1.6B |
2009 | 1.3B | 1.4B | 1.4B | 1.5B |
2008 | 0 | 861.1M | 1.0B | 1.2B |
2007 | 0 | 0 | 0 | 697.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 20, 2024 | bohnert denise m. | sold (taxes) | -132,571 | 93.69 | -1,415 | chief compliance officer |
Feb 20, 2024 | ginn scott g | sold (taxes) | -301,494 | 93.69 | -3,218 | evp, cfo & coo |
Feb 20, 2024 | north michael paul | sold (taxes) | -149,061 | 93.69 | -1,591 | chief information officer |
Feb 20, 2024 | muscato nick | sold (taxes) | -30,636 | 93.69 | -327 | chief strategy officer |
Feb 16, 2024 | ginn scott g | acquired | - | - | 16,553 | evp, cfo & coo |
Feb 16, 2024 | muscato nick | acquired | - | - | 5,518 | chief strategy officer |
Feb 16, 2024 | north michael paul | acquired | - | - | 8,277 | chief information officer |
Feb 16, 2024 | bohnert denise m. | acquired | - | - | 5,518 | chief compliance officer |
Feb 16, 2024 | ashworth richard m | acquired | - | - | 55,175 | president and ceo |
Feb 16, 2024 | holton adam y | acquired | - | - | 5,518 | chief people officer |
Which funds bought or sold AMED recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | reduced | -2.79 | -6,606 | 616,560 | -% |
Mar 21, 2024 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | reduced | -59.01 | -3,081,140 | 2,205,300 | 0.01% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -0.7 | 3,235,010 | 305,959,000 | 0.01% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 162 | 15,982,800 | 25,573,000 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -4.13 | -104,017 | 4,189,670 | 0.02% |
Feb 26, 2024 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | unchanged | - | 18,000 | 1,038,000 | 0.01% |
Feb 21, 2024 | Raleigh Capital Management Inc. | sold off | -100 | -2,802 | - | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 210,000 | 210,000 | 0.02% |
Feb 16, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | added | 1.64 | 73,106 | 2,180,110 | 0.01% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | reduced | -11.92 | -340,000 | 2,942,000 | -% |
Unveiling Amedisys Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Peers (Alternatives to Amedisys Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 454.6B | 371.6B | 20.31 | 1.22 | ||||
CI | 106.2B | 195.3B | 19.78 | 0.54 | ||||
CVS | 100.0B | 357.8B | 11.97 | 0.28 | ||||
HCA | 87.7B | 65.0B | 16.74 | 1.35 | ||||
CNC | 41.9B | 154.0B | 15.51 | 0.27 | ||||
UHS | 12.6B | 14.3B | 17.56 | 0.88 | ||||
DVA | 12.0B | 12.1B | 17.36 | 0.99 | ||||
MID-CAP | ||||||||
CHE | 9.7B | 2.3B | 35.74 | 4.3 | ||||
ACHC | 7.2B | 2.9B | -333.68 | 2.47 | ||||
AMN | 2.3B | 3.8B | 11.05 | 0.61 | ||||
AMEH | 2.3B | 1.4B | 37.6 | 1.65 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.93 | 1.59 | ||||
BKD | 1.2B | 3.0B | -6.6 | 0.41 | ||||
BEAT | 56.3M | - | -3.85 | - | ||||
AMS | 16.9M | 20.7M | 83.48 | 0.82 |
Amedisys Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 2.6% | 571 | 556 | 553 | 556 | 562 | 558 | 558 | 545 | 559 | 554 | 564 | 537 | 551 | 544 | 485 | 492 | 501 | 495 | 493 | 467 | 434 |
Costs and Expenses | 4.4% | 537 | 514 | 515 | 514 | 516 | 519 | 510 | 497 | 511 | 497 | 491 | 477 | 495 | 486 | 458 | 448 | 459 | 448 | 448 | 423 | 398 |
EBITDA Margin | -5.0% | 0.04* | 0.04* | 0.04* | 0.09* | 0.09* | 0.10* | 0.11* | 0.13* | 0.14* | 0.15* | 0.16* | 0.13* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 2.7% | 8.00 | 8.00 | 8.00 | 8.00 | 6.00 | 5.00 | 8.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 2.00 |
Income Taxes | -17.1% | 10.00 | 12.00 | 18.00 | 10.00 | 10.00 | 9.00 | 11.00 | 12.00 | 13.00 | 11.00 | 29.00 | 18.00 | 16.00 | -10.20 | 10.00 | 9.00 | 11.00 | 10.00 | 10.00 | 11.00 | 9.00 |
Earnings Before Taxes | -23.1% | 29.00 | 38.00 | -62.23 | 35.00 | 41.00 | 35.00 | 40.00 | 44.00 | 47.00 | 56.00 | 109 | 68.00 | 62.00 | 62.00 | 45.00 | 41.00 | 39.00 | 44.00 | 44.00 | 42.00 | 37.00 |
EBT Margin | -23.7% | 0.02* | 0.02* | 0.02* | 0.07* | 0.07* | 0.07* | 0.08* | 0.12* | 0.13* | 0.13* | 0.14* | 0.11* | - | - | - | - | - | - | - | - | - |
Net Income | -25.6% | 19.00 | 26.00 | -80.28 | 25.00 | 32.00 | 26.00 | 30.00 | 32.00 | 34.00 | 45.00 | 80.00 | 50.00 | 45.00 | 72.00 | 35.00 | 32.00 | 28.00 | 34.00 | 34.00 | 31.00 | 28.00 |
Net Income Margin | -466.5% | 0.00* | 0.00* | 0.00* | 0.05* | 0.05* | 0.05* | 0.06* | 0.09* | 0.09* | 0.10* | 0.11* | 0.10* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 639.6% | 58.00 | -10.83 | 59.00 | 25.00 | 39.00 | -15.19 | 56.00 | 48.00 | 4.00 | 60.00 | 67.00 | 52.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 1.6% | 2,060 | 2,027 | 1,982 | 1,947 | 1,976 | 1,982 | 2,001 | 1,908 | 1,857 | 1,938 | 1,600 | 1,573 | 1,567 | 1,603 | 1,645 | 1,440 | 1,263 | 1,212 | 1,206 | 1,184 | 717 |
Current Assets | 6.4% | 497 | 467 | 427 | 406 | 389 | 389 | 395 | 392 | 357 | 433 | 391 | 380 | 362 | 411 | 450 | 468 | 351 | 300 | 276 | 272 | 224 |
Cash Equivalents | 61.9% | 127 | 78.00 | 95.00 | 49.00 | 41.00 | 31.00 | 49.00 | 71.00 | 46.00 | 128 | 93.00 | 78.00 | 83.00 | 115 | 180 | 178 | 96.00 | 21.00 | 14.00 | 11.00 | 20.00 |
Net PPE | 5.5% | 42.00 | 40.00 | 36.00 | 33.00 | 16.00 | 17.00 | 18.00 | 17.00 | 18.00 | 20.00 | 21.00 | 22.00 | 24.00 | 24.00 | 25.00 | 26.00 | 28.00 | 30.00 | 30.00 | 30.00 | 29.00 |
Goodwill | 0% | 1,245 | 1,245 | 1,245 | 1,245 | 1,287 | 1,285 | 1,290 | 9.00 | 1,196 | 1,188 | 937 | 933 | 933 | 931 | 937 | 721 | 659 | 660 | 665 | 650 | 330 |
Liabilities | 0.7% | 940 | 934 | 922 | 814 | 870 | 913 | 962 | 888 | 881 | 989 | 724 | 784 | 756 | 845 | 923 | 760 | 621 | 609 | 643 | 663 | 234 |
Current Liabilities | 1.2% | 474 | 468 | 462 | 353 | 356 | 367 | 427 | 380 | 374 | 454 | 449 | 456 | 456 | 437 | 442 | 316 | 327 | 315 | 313 | 297 | 222 |
Long Term Debt | -1.4% | 362 | 367 | 370 | 373 | 419 | 443 | 442 | 429 | 432 | 435 | 179 | 231 | 205 | 301 | 393 | 380 | 232 | 232 | 266 | 304 | 6.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 11.00 | - | - | - | 10.00 | - | - | - | 2.00 |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 205 | - | - | - | 232 | - | - | - | 6.00 |
Shareholder's Equity | 2.6% | 1,067 | 1,040 | 1,061 | 1,133 | 1,052 | 1,070 | 1,039 | 1,021 | 976 | 949 | 876 | 790 | 811 | 758 | 722 | 680 | 642 | 603 | 563 | 521 | 483 |
Retained Earnings | 2.7% | 748 | 729 | 703 | 783 | 758 | 726 | 700 | 671 | 639 | 605 | 560 | 480 | 430 | 385 | 313 | 278 | 246 | 219 | 185 | 151 | 120 |
Additional Paid-In Capital | 1.3% | 787 | 777 | 769 | 759 | 755 | 751 | 743 | 737 | 728 | 721 | 714 | 707 | 698 | 690 | 666 | 656 | 645 | 635 | 623 | 614 | 604 |
Accumulated Depreciation | -1.6% | 92.00 | 94.00 | 91.00 | 105 | 101 | 102 | 100 | 99.00 | 97.00 | 100 | 99.00 | 98.00 | 95.00 | 102 | 101 | 98.00 | 96.00 | 101 | 99.00 | 97.00 | 95.00 |
Shares Outstanding | 0.1% | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | 33.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | -0.6% | 53.00 | 54.00 | 54.00 | 54.00 | 55.00 | 54.00 | 53.00 | 54.00 | 45.00 | 44.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Float | - | - | - | 2,600 | - | - | - | 3,000 | - | - | - | 6,900 | - | - | - | 5,500 | - | - | - | 2,800 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 712.7% | 60,311 | -9,843 | 60,759 | 25,961 | 40,883 | -13,630 | 57,409 | 48,621 | 5,166 | 61,767 | 67,958 | 54,002 | 65,912 | 83,083 | 133,922 | 6,035 | 75,220 | 47,455 | 59,266 | 20,059 | 64,033 |
Share Based Compensation | 29.8% | 9,400 | 7,243 | 9,108 | 3,273 | 610 | 3,495 | 5,148 | 7,347 | 5,940 | 4,397 | 6,156 | 7,307 | 6,972 | 7,124 | 6,725 | 5,909 | 6,589 | 6,298 | 5,538 | 6,615 | 5,234 |
Cashflow From Investing | -94.6% | -2,039 | -1,048 | -7,745 | 45,896 | -1,866 | -1,033 | -75,508 | -16,079 | -11,667 | -264,561 | -3,822 | -1,557 | -1,565 | -1,221 | -213,567 | -70,755 | -1,386 | -3,604 | -19,046 | -328,912 | -9,572 |
Cashflow From Financing | -114.7% | -13,425 | -6,254 | -10,953 | -56,890 | -16,344 | -2,641 | -4,046 | -7,402 | -75,938 | 238,356 | -49,834 | -57,458 | -96,443 | -146,736 | 82,160 | 146,042 | 1,899 | -36,996 | -36,872 | 299,178 | -48,242 |
Buy Backs | - | - | - | - | - | - | - | 17,351 | - | 14,999 | 10,805 | 1,188 | 72,886 | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Net service revenue | $ 2,236,382 | $ 2,223,199 | $ 2,214,112 |
Other operating income | 0 | 0 | 13,300 |
Cost of service, inclusive of depreciation | 1,245,509 | 1,260,425 | 1,233,356 |
General and administrative expenses: | |||
Salaries and benefits | 516,049 | 508,791 | 474,718 |
Non-cash compensation | 26,082 | 16,560 | 23,809 |
Merger-related expenses | 36,672 | 0 | 0 |
Depreciation and amortization | 17,747 | 24,935 | 30,901 |
Investment impairment | 0 | 3,009 | 0 |
Other | 237,929 | 228,707 | 212,713 |
Total operating expenses | 2,079,988 | 2,042,427 | 1,975,497 |
Operating income | 156,394 | 180,772 | 251,915 |
Other income (expense): | |||
Interest income | 3,270 | 178 | 49 |
Interest expense | (31,274) | (22,228) | (9,525) |
Equity in earnings (loss) from equity method investments | 10,760 | (45) | 4,949 |
Merger termination fee | (106,000) | 0 | 0 |
Gain on equity method investments | 0 | 0 | 31,098 |
Miscellaneous, net | 6,473 | 1,567 | 1,745 |
Total other (expense) income, net | (116,771) | (20,528) | 28,316 |
Income before income taxes | 39,623 | 160,244 | 280,231 |
Income tax expense | (50,559) | (42,545) | (70,065) |
Net (loss) income | (10,936) | 117,699 | 210,166 |
Net loss (income) attributable to noncontrolling interests | 1,189 | 910 | (1,094) |
Net (loss) income attributable to Amedisys, Inc. | $ (9,747) | $ 118,609 | $ 209,072 |
Basic earnings per common share: | |||
Net (loss) income attributable to Amedisys, Inc. common stockholders (usd per share) | $ (0.30) | $ 3.65 | $ 6.41 |
Weighted average shares outstanding (shares) | 32,599 | 32,517 | 32,642 |
Diluted earnings per common share: | |||
Net (loss) income attributable to Amedisys, Inc. common stockholders | $ (0.30) | $ 3.63 | $ 6.34 |
Weighted average shares outstanding (shares) | 32,599 | 32,653 | 32,972 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 126,450 | $ 40,540 |
Restricted cash | 12,413 | 13,593 |
Patient accounts receivable | 313,373 | 296,785 |
Prepaid expenses | 14,639 | 11,628 |
Other current assets | 30,060 | 26,415 |
Total current assets | 496,935 | 388,961 |
Property and equipment, net of accumulated depreciation of $92,422 and $101,364 | 41,845 | 16,026 |
Operating lease right of use assets | 88,939 | 102,856 |
Goodwill | 1,244,679 | 1,287,399 |
Intangible assets, net of accumulated amortization of $14,008 and $14,604 | 102,675 | 101,167 |
Other assets | 85,097 | 79,836 |
Total assets | 2,060,170 | 1,976,245 |
Current liabilities: | ||
Accounts payable | 28,237 | 43,735 |
Payroll and employee benefits | 136,835 | 125,387 |
Accrued expenses | 140,049 | 137,390 |
Termination fee paid by UnitedHealth Group | 106,000 | 0 |
Current portion of long-term obligations | 36,314 | 15,496 |
Current portion of operating lease liabilities | 26,286 | 33,521 |
Total current liabilities | 473,721 | 355,529 |
Long-term obligations, less current portion | 361,862 | 419,420 |
Operating lease liabilities, less current portion | 62,751 | 69,504 |
Deferred income tax liabilities | 40,635 | 20,411 |
Other long-term obligations | 1,418 | 4,808 |
Total liabilities | 940,387 | 869,672 |
Commitments and Contingencies | ||
Equity: | ||
Preferred stock, $0.001 par value, 5,000,000 shares authorized; none issued or outstanding | 0 | 0 |
Common stock, $0.001 par value, 60,000,000 shares authorized; 38,131,478 and 37,891,186 shares issued; and 32,667,631 and 32,511,465 shares outstanding | 38 | 38 |
Additional paid-in capital | 787,177 | 755,063 |
Treasury stock at cost, 5,463,847 and 5,379,721 shares of common stock | (468,626) | (461,200) |
Retained earnings | 747,925 | 757,672 |
Total Amedisys, Inc. stockholders’ equity | 1,066,514 | 1,051,573 |
Noncontrolling interests | 53,269 | 55,000 |
Total equity | 1,119,783 | 1,106,573 |
Total liabilities and equity | $ 2,060,170 | $ 1,976,245 |
 | Mr. Richard M. Ashworth |
---|---|
 | www.amedisys.com |
 | 20000 |